|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 31/713 | |
| A61K 38/39 | |||
| A61K 39/395 | |||
| A61K 47/36 | |||
| A61P 27/02 | |||
| A61K 9/00 | |||
| A61K 9/08 | |||
| A61K 47/34 | |||
| C12N 15/113 | |||
| C07K 16/22 | |||
| A61K 48/00 |
| (11) | Number of the document | 2446890 |
| (13) | Kind of document | T |
| (96) | European patent application number | 12151895.5 |
| Date of filing the European patent application | 2008-04-28 | |
| (97) | Date of publication of the European application | 2012-05-02 |
| (45) | Date of publication and mention of the grant of the patent | 2013-09-18 |
| (46) | Date of publication of the claims translation |
| (30) | Number | Date | Country code |
| 742350 | 2007-04-30 | US |
| (72) |
Hughes, Patrick M., US
De Vries, Gerald W., US
Lyons, Robert T., US
Trogden, John T., US
Whitcup, Scott M., US
|
| (73) |
Allergan, Inc.,
2525 Dupont Drive, Irvine, CA 92612,
US
|
| (54) | High viscosity macromolecular compositions for treating ocular conditions |
| High viscosity macromolecular compositions for treating ocular conditions |